Status:
RECRUITING
Comparison Of Percutaneous Mechanical Thrombectomy With Different Access in Treatment of Acute Deep Venous Thrombosis
Lead Sponsor:
RenJi Hospital
Collaborating Sponsors:
First People's Hospital of Hangzhou
Chengdu University of Traditional Chinese Medicine
Conditions:
Deep Vein Thrombosis
Eligibility:
All Genders
18-85 years
Brief Summary
The study aims to compare the modified approach through ipsilateral deep calf venous access of contralateral femoral venous access with the traditional approach through ipsilateral popliteal venous ac...
Detailed Description
Acute deep venous thrombosis (DVT) is associated with development of post-thrombotic syndrome (PTS). Early removal of iliofemoral thrombosis by percutaneous mechanical thrombectomy (PMT) may reduce th...
Eligibility Criteria
Inclusion
- Age between 18-85 years old;
- Acute DVT occurred no more than 14 days since the onset of disease;
- DVT treated by percutaneous mechanical thrombectomy
- Informed consent signed by patients.
Exclusion
- Patients who are known to be allergic to heparin, low molecular weight heparin, or contrast agent;
- Women during pregnancy and lactation;
- Patients with other diseases that may cause difficulty in the study or significantly shorten the life expectancy of patients (\<6 months);
- Patients who are unable or unwilling to participate in the study.
Key Trial Info
Start Date :
January 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 31 2027
Estimated Enrollment :
210 Patients enrolled
Trial Details
Trial ID
NCT06124768
Start Date
January 1 2021
End Date
October 31 2027
Last Update
December 4 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Renji Hospital
Shanghai, Shanghai Municipality, China, 200127